Plant-derived, asparagine residue-specific endoprotease cDNA and a gene

FIELD OF THE INVENTION
The present invention relates to a plant-derived, asparagine residue-specific endoprotease cDNA and a gene.
BACKGROUND OF THE INVENTION
Asparagine residue-specific endoproteases refer to enzymes that split peptide etc. in an amino acid sequence of peptide or protein at the C-terminal side of asparagine residue. Among them, the asparagine residue-specific endoprotease derived from plants is called legumaturain.
Although its enzymatic activity was confirmed in various higher plants, legumaturain was highly purified by no other person than the present inventors since it is very unstable.
Storage proteins of plants are synthesized initially as a prepro-protein, which will not be converted into the form of a mature protein until it is under the action of legumaturain. The storage proteins of plants have no problem on safety and are an excellent source of protein so that there is an earnest demand in food industries to produce it on a large scale.
Accordingly, it is also earnestly demanded to produce on a large scale a highly pure legumaturain that is necessary for the synthesis of the storage proteins.
However, from the reason as described above, it has been very difficult to purif y legumaturain and the demand has never been satisfied yet.
SUMMARY OF THE INVENTION
Obtainment and utilization of cDNA and gene of legumaturain ha ve a possibility t o open the way to large-scale production of the targeted enzyme. Also, legumaturain can be utilized in increasing the stability of the targeted enzyme or improvement in enzymatic activity of the targeted enzyme by use of a site-specific mutation method.
Therefore, an object of the present invention is to obtain genetic information of legumaturain and make it possible to produce the targeted enzyme on a large scale.
The present inventors have highly purified legumaturain and tried to clone cDNA and gene of legumaturain based on its amino acid sequence. As a result, they have been successful in elucidating the entire structure of cDNA and gene of legumaturain and thus completed the present invention.
That is, based on the analyses of the amin o acid sequence of highly purified legumaturain, a synthetic oligonucleotide having degeneration was synthesized. Then, mRNA was extracted from an early ripening stage soybean seed and cDNA complementary to the extracted mRNA was prepared. The prepared synthetic oligonucleotide and cDNA were subjected to polymerase chain reaction (PCR) to clone a partial cDNA of legumaturain.
On the other hand, the same mRNA of early ripening stage soybean seed described above was used to synthesize double strand cDNA, which was incorporated into a phage vector by means of an adapter to construct cDNA library.
The partial legumaturain cDNA obtained by the PCr me thod was labeled before it was used as a probe in screening from the cDNA library to clone a full-length legumaturain cDNA. Analyses of the primary structure of cDNA resulted in the determination of the entire amino acid sequence of legumaturain including a signal peptide sequence.
An oligonucleotide primer based on the cDNA sequence was synthesized and on the other hand each DNA was extracted from germinated soybean and then purified. This was used as a template in a subsequent PCR method to clone a legumaturain gene.
Therefore, according to a first aspect of the present invention, there is provided a cDNA encoding a plant-derived, asparagine residue-specific endoprotease having an amino sequence described in SEQ ID NO: 1 in the sequence listing.
Further, according to a second a spect of the present invention, there is provided a gene encoding a plant-derived, asparagine residue-specific endoprotease having an amino sequence described in SEQ ID NO: 2 in the sequence listing.
Utilization of cDNA and gene according to the present invention enables efficient and large-scale production of an asparagine residue-specific endoprotease (legumaturain), which has been considered difficult to be purified because of its instability.
Furthermore, the present invention can contribute to an increase in the stability of legumaturain, improvement in its enzymatic activity and the like by utilizing a site-specific mutation method.
DETAILED DESCRIPTION OF THE INVENTION
Hereafter, the present invention will be described in detail.
In a first embodiment, the present invention relates to a cDNA that encodes a plant-derived, asparagine residue-specific endoprotease having an amino sequence described in SEQ ID NO: 1 and SEQ ID NO. 2 in the sequence listing.
In the present invention, the plant-derived, asparagine residue-specific endoprotease, i.e., legumaturain, is an enzyme that has an activity of splitting peptide etc. in the amino acid sequence of peptide or protein at the C-terminal side of asparagine residue.
The present inventors were successful in obtaining the above-described cDNA of the present invention as follows.
(1) First, legumaturain contained in plant was extracted and purified.
Legumaturain is contained in storage proteins in various plans, particularly seeds thereof. For example, when legumaturain is to be extracted from soybean seeds, it is preferred to use the seeds between early growing stage and ripe stage, particularly thes e in early growing stage to later growing stage.
Here, to obtain only legumaturain, it is necessary to highly purify a plant as a raw material. For example, plant seeds between early growing stage and ripe stage are pulverized and extracted with a suitable buffer solution and soluble fractions were collected, dialyzed and then subjected to solid-liquid separation. The resultant crude enzyme solution is subjected to hydrophobic chromatography, gel filtration, etc. As a result, substantially pure legumaturain can be obtained by this purification procedure.
(2) Of the amino acid sequence of the resultant purified legumaturain, N-terminal side amino acid sequence was determined. The determination of the amino acid sequence can be carried out by Edman degradation method (PTC method). This can be performed in a simple and easy manner by use of an automatic amino acid sequence analyzer.
(3) On the other hand, besides (2) above, a partial amino acid sequence of purified legumaturain was obtained. First, legumaturain was enzymatically digested to short peptides. Each peptide sample was fractionated with high performance liquid chromatography, etc. and amino acid sequence of each sample, i.e., amino acid sequence of inner portion of legumaturain, was determined.
The determination of amino acid sequence can be carried out in the same manner as described in (2) above.
Among the amino acid sequences thus determined, there were selected two oligonucleotides that have degeneration and these were used as a primer in the PCR reaction described later on (cf. SEQ ID NOS: 3 and 4 in the sequence listing).
(4) Next, RNA was extracted from the plant seeds and cDNA complementary thereto was synthesized. RNA extraction from the plant can be carried out by using the SDS-phenol method according to Fukazawa C. et al., Journal of Biological Chemistry, 200, 6234-6239 (1985).
From the whole extracted RNA was prepared Poly (A)+RNA, which was subjected to a reverse transcription reaction using a reverse transcriptase using oligo (dT) as a primer to obtain a single strand cDNA.
(5) The single strand cDNA was used as a template and PCR was carried out with the previously prepared synthetic oligonucleotide (SEQ ID NOS: 3 and 4) tocloneapartial cDNA (400 bp) of legumaturain.
The obtained band was subcloned into a vector, which then was analyzed to see if it contained rhe previously analyzed inner amino acid sequence of legumaturain. As a result, said band was confirmed to be a partial cDNA of legumaturain.
(6) Then, a double-stranded cDNA was synthesized using mRNA of the same plant seed and incorporated into a phage vector through an adapter to construct cDNA library.
To make cDNA library, the Okayama-Berg method and the Gubler-Hoffman method can be used. Due to simplicity, the latter method is preferred. Hereafter, description will be made on the case in which the Gubler-Hoffman method was adopted.
First, a double-stranded cDNA is synthesized from the above-mentioned poly(A)+RNA. To the obtained cDNA is ligated an adapter containing restriction enzyme sites such as EcoRI, NotI, BamHI, et. and cDNA is split with restrictio n enzymes. By polyacrylamide gel electrophoresis, cDNA having 500 bp or more were cut and collected from the gel and then adapter was removed therefrom.
Thereafter, a phosphate group was iintroduced to the 5'-position of the resultant nucleotide, which then was split with a restriction enzyme and ligated to .lambda. gt10 phage vector arm (manufactured by Takara Shuzo) which had been previously dephosphorylated. This was packaged in .lambda. phage. In this manner, cDNA library was prepared.
(7) The partial legumaturain cDNA obtained by the PCR method described in (5) above was labeled and used as a probe in screening from the cDNA library described in (6) above. Then, a full-length legumaturain cDNA was cloned.
The screening can be performed by using the previously obtained legumaturain partial cDNA after label ing with a radioisotope, etc. as a probe and conducting plaque hybridization to the cDNA library having about 100,000 plaques.
As a result, of the about 100,000 plaques, several plaques that were found to be positive were separated.
The separated positive plaques after purification were infected to Escherichia coli cells and amplified phages, followed by purification of phage particles. The purification of phage DNA can be performed, for example, by ultracentrifugation using CsCl stepwise density gradient.
From the purified phage DNA was split an insert with a restriction enzyme and purified by agarose gel electrophoresis, for example. The product was subcloned in a plasmid vector and then DNA sequencing therefor was performed.
As a result, there was obtained a cDNA having the amino acid sequence described in SEQ ID NO: 1 and SEQ ID NO. 2 of the sequence listing. The cDNA is the cDNA of the present invention according to the first aspect.
Said sequence contains full-length legumaturain. Comparing the database of EMBL, GenBank, etc., revealed that the sequence determined is quite a novel sequence.
The cDNA of the present invention according to the first aspect consists of 1055 bp in full length, of which 14 bp is occupied by polyA. Thenumber of amino acids is in total 241 residues counted from the starting methionine and the number of signal peptides was 21 residues. And there was 220 residues portion from N-terminal sequence of a mature-type protein to C-terminal of an amino acid presumed from the cDNA cloned.
The results of C-terminal analyses and the results of molecular weight measurement by ion spray mass spectrometry indicated that legumaturain is a protein of preprotein-type which receives process on the C-terminal side.
In the sequence, the bonding site of a sugar chain that is involved in the legumaturain activity is the 71st to 78th amino acids portion of the amino acid sequence in the SEQ ID NO: 2 in the sequence listing. The arrangement of this portion is a basic amino acid--hydrophobic amino acid--asparagine (sugar chain)--hydrophobic amino acid--threonine/serine-hydrophobic amino acid--acidic amino acid--cystein from the N-terminal side.
The sugar chain bonding site is considered to participate in the stabilization of legumaturain, which has an ability of specifically splitting an amino acid sequence on the C-terminal side of asparagine residue. Deletion of the sugar chain results in an abrupt decrease in enzymatic activity.
Next, a second embodiment of the present invention will be described.
In a second embodiment, the present invention relates to a full-length gene of legumaturain obtained by primary structure a nalyses of cDNA according to the first aspect of the present invention.
First, two oligonucleotide primers (cf. SEQ ID NOS: 5 and 6 in the listing), i.e., 25 mer and 26 mer, were synthesized based on the base sequence of cDNA in the SEQ ID NO: 1 in the sequence listing.
On the other hand, DNA was prepared from soybean seedlings. The preparation can be performed, for example, by the CTAB method (Fukazawa C. et al., Journal of Biological Chemistry, 200, 6234--6239
With the obtain ed DNA as a template, a PCR method was practiced by using the primers described in SEQ ID NOS: 11 and 12.
As a result, an about 3.1 bp single band was obtained. After subcloning the band in a TA vetor (pCR2.1, manuf actured by invitrogen), DNA sequencing was carried out by the method described above. As a result, the base sequence described in SEQ ID NO: 3 in the sequence listing was obtaineed.
The full-length (cf. SEQ ID NO: 3 of the sequence listing) of the gene of the present invention according to the second aspect is 3077 bp, which is interrupted by four introns to be divided into 5 exons.
The base numbers in respective introns were 67, 705, 1113, and 200 bp, respectively, from the first intron. On the other hand, the base numbers in respective exons were 321, 66, 141, 93, and 420 bp, respectively, from the first exon (cf. SEQ ID NO: 3 in the sequence listing).
The sugar chain bonding site participating in exhibiting activity which was present in the above-mentioned cDNA existed on the first exon (cf. 71st to 78th amino acids in the amino acid sequence described in SEQ ID NO: 3 and SEQ ID NO: 4 in the listing).
The gene encoding the plant-derived, asparagine residue specific endoprotease having the amino acid sequence described in SEQ ID NO: 3 and SEQ ID NO: 4-8 in the sequence listing is the asparagine residue-specific endoprotease gene according to the second aspect of the present invention.
Utilization of the cDNA and gene of the present invention as described above enables large scale and yet efficient production of asparagine residue-specific endoprotease (legumaturain).
Those having amino acid sequences obtainable by deletion, substitution or addition of one or more of amino acid residues in the amino acid sequence described in SEQ ID NO: 1 and 2 in the sequence listing but exhibiting similar effects are encompassed by the present invention. Similarly, those having amino acid sequences obtainable by deletion, substitution or addition of one or more of amino acid residues in the amino acid sequence described in SEQ ID NO: 3 and SEQ ID NO: 4-8 in the sequence listing but exhibiting similar effects are also embraced by the present invention.

EXAMPLES
Hereafter, the present invention will be described in detail by examples. However, the present invention should not be construed as being limited thereto.
Example 1
Determination of Amino Acid Sequence of Legumaturain and Cloning of Partial cDNA by a PCR Methode
(1) Preparation of a Template
From soybean seeds after 13 days from the flowering were extracted whole RNA by use of the SDS-phenol method as described in Fukazawa C. e t al., Journal of Biological Chemistry, 200, 6234-6239 (1985). Then, Poly(A)+rNA was prepared from the extracted whole RNA using Poly A Tract kit (manufactured by Promega).
Using 1 .mu.g of the prepared Poly(A)+RNA reverse transcription reaction was performed using oligo(dT) as a primer with 100 U of a reverse transcriptase (RAV-2, manufacture d by Takara Shuzo) at 42.degree. C. for 60 minutes to obtain a single strand cDNA. To decompose the remaining RNA in the reaction mixture, the obtained cDNA was subjected to digestion with alkali (NaOH) overnight at 25.degree. C. in a final concentration of 0.5 N--NaOH. After the decomposition with alkali, the reaction mixture was neutralized with 0.5 M (final concentration) of HEPES buffer solution at pH 7.2 and passed through a gel filtration column (.phi.0.8 cm.times.27 cm) packed with Sephadex G-50 (manufactured by Amersham Pharmacia) to remove the decomposed RNA. The thus-obtained single strand cDNA was used in the following PCR method.
(2) Preparation of Primers
The N-terminal amino acid sequence of highly purified legumaturain was determined using gas phase amino acid sequencer (Type 477A, manufactured by Perkin Elmer).
On the other hand, legumaturain was decomposed by the method described by Arahira M. and Fukazawa C., Plant Molecular Biology, 25, 597-6o5 (1994) using V8 protease (manufactured by Takara Shuzo) and lysyl endopeptidase (manufactured by Wako Pure Chemical Industry).
After the decomposition, each sample was fractionated by high performance liquid chromatography column (LC-6AD, manufactured by Shimadzu) connected to a reverse phase column (Silica ODS 120T .phi.4.6 mm.times.150 mm, manufactured by Tosoh) in a solvent system with a liner concentration gradient of 0.1% TFA--0.1% TFA/60% acetonitrile.
The obtained peptide was determined for its N-terminal amino acid sequence using a gas phase amino acid sequencer (Type 477A, manufactured by Perkin Elmer) similarly to the determination of N-terminal amino acid sequence and the obtained sequence was defined as an inner amino acid sequence.
Of the amino acid sequences, those sequences that are suitable as a primer for PCR were examined and two primers having degeneracy, 20 mer and 32 mer, were synthesized (cf. SEQ ID NOS: 9 and 10 in the sequence listing).
(3) Legumaturain Partial cDNA Cloning by PCR
Using the oligonucleotide primer synthesized in (2) above, PCR reaction was carried out with the single strand cDNa synthesized in (1) above as a template.
As the conditions for PCR, TaKaRa ExTaq (manufactured by Takara Shuzo) was used in 2.5 U per reaction as a Taq polymerase. The primer was used in a final concentration of 0.4 .mu.M and dNTP mix was used in a final concentration of 0.2 mM. The single strand cDNA as a template was used in an amount of 10 ng.
The gene amplifying apparatus used is TaKaRa PCR Thermal Cycler 480 (manufactured by Takara Shuzo), which was operated at a denaturation temperature of 95.degree. C. for 30 seconds and at an annealing temperature of 56.degree. C. for 30 seconds, an elongation reaction temperature of 72.degree. C. for 1 minute and 30 seconds at 35 cycles.
As a result, an about 400 bp single band was obtained, and then subcloned in a TA vector ([pCR2.1] (manufactured by Invitrogen) From the cloned Escherichia coli cells were prepared plasmid DNA according to the conventional method (Maniatis T. et al., "Molecular Cloning" C.old Spring Har bor Labo. (1982).
The prepared plasmid was subjected to fluorescence auto-seqencing using a DNA sequencer DSQ1000 manufactured by Shimadzu. As a result, it revealed that the subcloned band contained the inner amino acid sequence of legumaturain that were determined in (2) above.
This confirmed that the cloned band was a partial cDNA of legumaturain.
Example 2
Preparation of cDNA Library of Soybean in Early Growing Stage
From 2.5 .mu.g of the poly(A)+RNA obtained in Example 1 (1) was synthesized double-stranded DNA using a cDNA synthesis kit (manufactured by Amersham Pharmacia) which was based on the principle of Gubler-Hoffman method while monitoring the progress of synthesis with addition of [.sup.32 P]-dCTP.
One (1) nmol of EcoRI-NotI-BamHI adapter (manufactured by Takara Shuzo) was ligated to the double-stranded cDNA using a ligation pack manufactured by Nippon Gene. The cDNA was subjected to polyacrylamide gel electrophoresis according to the method described by Fukazawa C. et al., Journal of Biological Chemistry, 200, 6234-6239 (1985) to obtain cDNA having 500 bp length or more by cutting gel, and the adapter was removed.
Since the adapter contains no phosphate at the 5'-position, a phosphate group was introduced by use of T4 polynucleotide kinase (manufactured by Nippon Gene).
Thereafter, the cDNA was split with EcoRI and the resulting fragments were ligated to .lambda.gt10 phage vector arm (Takara Shuzo) previously dephosphorylated in the same manner as described above with the ligation pack manufactured by Nippon Gene and then packaged in .lambda.phage using an in vitro packaging kit (Amersham Pharmacia).
Thus, soybean grown seed (13 days after the flowering) cDNA library was prepared.
Example 3
Cloning of Full-length Legumaturain cDNA
Legumaturain partial cDNA obtained in Example 1 was labeled by a PCR method with [.sup.32 P]-dCTP according to the method of Arahira M. and Fukazawa C., Plant Molecular Biology, 25, 597-605 (1994)
This was used as a probe and plaque hybridization was practiced from the library of soybean grown seed (13 days after the flowering) prepared in Example 2 according to the method described by Arahira M. and Fukazawa C., Plant Molecular Biology, 25, 597-605 (1994). As a result, several positive plaques were separated from about 100,000 plaques of cDNA.
The positive plaques were purified and infected to Escherichia coli cells to amplify the phage and the phage particles were purified by ultracentrifugation using CsCl stepwise density gradient to obtain purified phage DNA.
The purified phage DNA was split with BamHI to obtain an insert, which was purified from agarose gel and then subcloned in pUC19 plasmid vector. Thereafter, DNA s equencing was practiced in the same manner as in Example 1.
Results of analyses revealed that the resultant cDNA contained full-length legumaturain sequence and contained the base sequence and amino acid sequence described in SEQ ID NO: 1 in the sequence listing. Comparison with the databases of EmBL, GenBanke etc. indicated that the cDNA is of quite a novel sequence.
The total length of the cDNA is 1055 bp, of which 14 bp is occupied by poly A. The number of amino acids is in total 241 residues co unted from the starting methionine. The number of amino acids of s ignal peptide is 21 residues. There was 220 residues portion from N-terminal sequence of a ma ture-type protein to C-terminal of an amino acid presumed from the cDNA cloned. Th e results of C-terminal analyses and the results of molecular weight measurement by ion spray mass spectrometry indicated that legumaturain is a protein of preprotein-type which receives process on the C-terminal side.
In the sequence, the bonding site of a sugar chain that is involved in the legumaturain activity was only one (the 71st to 78th amino acids portion of the amino acid sequence in the SEQ ID NO: 1 and SEQ ID NO: 2 in the sequence listing). The arrangement of this bonding site was found to be a basic amino acid (arginine)--hydrophobic amino acid (alanine)--asparagine (sugar chain)--hydrophobic amino acid (alanine)--threonine/serine--hydrophobic amino acid (phenylalanine)--acidic amino acid (aspartic acid)--cystein.
Example 4
Legumaturain Gene Cloning
Based on the base sequence of the cDNA obtained in Example 3, two types of 25 mer and 26 mer oligonucleotide primers were synthesized (cf. SEQ ID NOS: 11 and 12 in the sequence listing).
Nuclear DNA was prepared from soybean seedlings by the CTAB method (Fukazawa C. et al., Nucleic Acid Research, 8117 (1987)). Using 10 ng of the DNA as a template, PCR method was practiced under the same conditions as in Example 1.
As a result, an about 3.1 kbp sin gle band was obtained. This was subcloned in a TA vector [pCR 2.1] (manufactured by Invitrogen) and then DNA sequencing thereof was carried out by th e method described in Example 3. Results of analyses indicated that the cloned gene had the same base sequence as described in SEQ ID NO: 3 in the sequence listing.
The full-length of the gene was found to be 3077 bp, which was interrupted by four introns to be divided into 5 exons. The base numbers in respective introns were 67, 705, 1113, and 200 bp, respectively, from the first intron. On the other hand, the base numbers in respective exons were 321, 66, 141, 93, and 420 bp, respectively, from the first exon (cf. SEQ ID NO: 3 in the sequence listing)--Note that the sugar chain bonding site participating in exhibiting activity existed on the first exon.
__________________________________________________________________________# SEQUENCE LISTING- <160> NUMBER OF SEQ ID NOS: 12- <210> SEQ ID NO 1<211> LENGTH: 1055<212> TYPE: DNA<213> ORGANISM: Glycine max<220> FEATURE:<221> NAME/KEY: CDS<222> LOCATION: (85)..(810)- <400> SEQUENCE: 1- ttggtggtag ctgttacgag tcagcaagag agaaatatct tgttgagttg at - #ttctgatc 60- ccaaattgag tttgagtttc agcc atg gta tct gtt tct c - #tg ctc tta ttc 111#Leu Leu Leu Phel Ser Val Ser# 5 1- cta tct ttc ttt gcc ttc ttt gca ccc tct ga - #a tct cac gac aaa gtc 159Leu Ser Phe Phe Ala Phe Phe Ala Pro Ser Gl - #u Ser His Asp Lys Val# 25- tcg ttg gaa ttg tac tac gaa agc tta tgc cc - #c tac agc gcc aac ttc 207Ser Leu Glu Leu Tyr Tyr Glu Ser Leu Cys Pr - #o Tyr Ser Ala Asn Phe# 40- atc gtg aat cac ctc cca aaa atc ttc acc cc - #a gat ctt gcc cca atc 255Ile Val Asn His Leu Pro Lys Ile Phe Thr Pr - #o Asp Leu Ala Pro Ile# 55- gtt cac ctc aaa ctc gtt cct tgg ggc aat gc - #c aaa ctc cgt gcc aac 303Val His Leu Lys Leu Val Pro Trp Gly Asn Al - #a Lys Leu Arg Ala Asn# 70- gcc acc ttt gac tgc cag cat ggg cca tat ga - #g tgc ttg ctg aac aca 351Ala Thr Phe Asp Cys Gln His Gly Pro Tyr Gl - #u Cys Leu Leu Asn Thr# 85- gtt gaa gcc tgt gca att cac atc tgg cct ca - #a ctc agc aaa cat ttt 399Val Glu Ala Cys Ala Ile His Ile Trp Pro Gl - #n Leu Ser Lys His Phe#105- cct ttc atc tac tgt gtt gag gat ctg gtg tt - #t cag agt aag cgt gag 447Pro Phe Ile Tyr Cys Val Glu Asp Leu Val Ph - #e Gln Ser Lys Arg Glu# 120- gaa tgg gaa tct tgt ttt gag aaa ctg gat ct - #t gat tcg gaa cct att 495Glu Trp Glu Ser Cys Phe Glu Lys Leu Asp Le - #u Asp Ser Glu Pro Ile# 135- aat cag tgt tat aat agt gaa cat gga aaa ca - #g ttg gag cta caa tat 543Asn Gln Cys Tyr Asn Ser Glu His Gly Lys Gl - #n Leu Glu Leu Gln Tyr# 150- gca gct gaa aca agt gct ctg gag cct cct ca - #c aag tat gtt cct tgg 591Ala Ala Glu Thr Ser Ala Leu Glu Pro Pro Hi - #s Lys Tyr Val Pro Trp# 165- gta gtt gtg gat gga gaa cca ctc tat gag ga - #t tat gag aac ttc tta 639Val Val Val Asp Gly Glu Pro Leu Tyr Glu As - #p Tyr Glu Asn Phe Leu170 1 - #75 1 - #80 1 -#85- agc tat ctt tgt aag gct tat aaa ggc act gt - #t aca ccc caa agt tgc 687Ser Tyr Leu Cys Lys Ala Tyr Lys Gly Thr Va - #l Thr Pro Gln Ser Cys# 200- acc caa gca tca tac cta aga gaa gtg aat gc - #a aag cct aag cat tcg 735Thr Gln Ala Ser Tyr Leu Arg Glu Val Asn Al - #a Lys Pro Lys His Ser# 215- gtt tgc tac aag gac agt ggg att atg cta ac - #a tgg gaa aaa gtg agg 783Val Cys Tyr Lys Asp Ser Gly Ile Met Leu Th - #r Trp Glu Lys Val Arg# 230- tca acc att gca tca tgg atg cac tag atgaatctt - #g gcagtgcatt 830Ser Thr Ile Ala Ser Trp Met His# 240- ttagatgtgc caatgctgca tttagtagca gtttgttcgt gttatcttgt gt - #gtagttgt 890- gttgatccct ccaaaagtgc aaatagaact tgtgatgcac ataaaaccat at - #cgtactct 950- cataaaaaaa ataaaaccat gatgtgtatg tgtatgaggt acttaagtac aa - #tatatata1010# 1055ta agtgcaattc taaaaaaaaa aaaaa- <210> SEQ ID NO 2<211> LENGTH: 241<212> TYPE: PRT<213> ORGANISM: Glycine max- <400> SEQUENCE: 2- Met Val Ser Val Ser Leu Leu Leu Phe Leu Se - #r Phe Phe Ala Phe Phe# 15- Ala Pro Ser Glu Ser His Asp Lys Val Ser Le - #u Glu Leu Tyr Tyr Glu# 30- Ser Leu Cys Pro Tyr Ser Ala Asn Phe Ile Va - #l Asn His Leu Pro Lys# 45- Ile Phe Thr Pro Asp Leu Ala Pro Ile Val Hi - #s Leu Lys Leu Val Pro# 60- Trp Gly Asn Ala Lys Leu Arg Ala Asn Ala Th - #r Phe Asp Cys Gln His# 80- Gly Pro Tyr Glu Cys Leu Leu Asn Thr Val Gl - #u Ala Cys Ala Ile His# 95- Ile Trp Pro Gln Leu Ser Lys His Phe Pro Ph - #e Ile Tyr Cys Val Glu# 110- Asp Leu Val Phe Gln Ser Lys Arg Glu Glu Tr - #p Glu Ser Cys Phe Glu# 125- Lys Leu Asp Leu Asp Ser Glu Pro Ile Asn Gl - #n Cys Tyr Asn Ser Glu# 140- His Gly Lys Gln Leu Glu Leu Gln Tyr Ala Al - #a Glu Thr Ser Ala Leu145 1 - #50 1 - #55 1 -#60- Glu Pro Pro His Lys Tyr Val Pro Trp Val Va - #l Val Asp Gly Glu Pro# 175- Leu Tyr Glu Asp Tyr Glu Asn Phe Leu Ser Ty - #r Leu Cys Lys Ala Tyr# 190- Lys Gly Thr Val Thr Pro Gln Ser Cys Thr Gl - #n Ala Ser Tyr Leu Arg# 205- Glu Val Asn Ala Lys Pro Lys His Ser Val Cy - #s Tyr Lys Asp Ser Gly# 220- Ile Met Leu Thr Trp Glu Lys Val Arg Ser Th - #r Ile Ala Ser Trp Met225 2 - #30 2 - #35 2 -#40- His- <210> SEQ ID NO 3<211> LENGTH: 3077<212> TYPE: DNA<213> ORGANISM: Glycine max<220> FEATURE:<221> NAME/KEY: CDS<222> LOCATION: (85)..(321)<220> FEATURE:<221> NAME/KEY: CDS<222> LOCATION: (389)..(454)<220> FEATURE:<221> NAME/KEY: CDS<222> LOCATION: (1160)..(1300)<220> FEATURE:<221> NAME/KEY: CDS<222> LOCATION: (2414)..(2506)<220> FEATURE:<221> NAME/KEY: CDS<222> LOCATION: (2707)..(2895)- <400> SEQUENCE: 3- ttggtggtag ctgttacgag tcagcaagag agaaatatct tgttgagttg at - #ttctgatc 60- ccaaattgag tttgagtttc agcc atg gta tct gtt tct c - #tg ctc tta ttc 111#Leu Leu Leu Phel Ser Val Ser# 5 1- cta tct ttc ttt gcc ttc ttt gca ccc tct ga - #a tct cac gac aaa gtc 159Leu Ser Phe Phe Ala Phe Phe Ala Pro Ser Gl - #u Ser His Asp Lys Val# 25- tcg ttg gaa ttg tac tac gaa agc tta tgc cc - #c tac agc gcc aac ttc 207Ser Leu Glu Leu Tyr Tyr Glu Ser Leu Cys Pr - #o Tyr Ser Ala Asn Phe# 40- atc gtg aat cac ctc cca aaa atc ttc acc cc - #a gat ctt gcc cca atc 255Ile Val Asn His Leu Pro Lys Ile Phe Thr Pr - #o Asp Leu Ala Pro Ile# 55- gtt cac ctc aaa ctc gtt cct tgg ggc aat gc - #c aaa ctc cgt gcc aac 303Val His Leu Lys Leu Val Pro Trp Gly Asn Al - #a Lys Leu Arg Ala Asn# 70- gcc acc ttt gac tgc cag gtactctctt ctccaatctt at - #acacactc 351Ala Thr Phe Asp Cys Gln 75#tat gag tgc 406aat tctgatgaca attgcag cat ggg cca# His Gly Pro Tyr Glu Cys# 85- ttg ctg aac aca gtt gaa gcc tgt gca att ca - #c atc tgg cct caa ctc 454Leu Leu Asn Thr Val Glu Ala Cys Ala Ile Hi - #s Ile Trp Pro Gln Leu# 100- gtaagtaaca attgctgtgc ctttgcccct ttctttcttt ctttcttttt tc - #ttttttct 514- ttgatttggg atcagaactt aagaatgctt tttttattat tataatatta tg - #ttattatt 574- acggattatt cagcatcgat tttttcagat gattaatttt tattggattt tg - #attaggtt 634- attttcttcc aattattttt tttatccaaa aaggagatga agttgttggt ga - #acttagga 694- gtgcctttat tattattgtt attatgttat tgttaaggag tattcattga tt - #ttatagat 754- gattaatttt cattggatca cctttgatta ggttatttcc tttcaattat tt - #tatttttt 814- atgaaaaagg agatgaagtc tggtgccacc tggacgaatg agttgttggt ga - #acttagaa 874- gtactattat aattatgata aattttgaaa aataaaaata aaaaaggagt ac - #ttttggtc 934- agtgtaacag tgctttagaa agatgctcta gcttgagcac tgtgcttaag tt - #gctataaa 994- ttcctgttat ccgagtttga ttcctatgga taaagttgtt attataaatt ct - #tggcacct1054- gagttcgagt tcaatttgta cggataaaaa agtttagcag tgctttgcat gt - #gtacctcg1114#aaa cat ttt 1171tgtt ttatgtaaat cacactcttt tgcag agc# Ser Lys H - #is Phe# 105- cct ttc atc tac tgt gtt gag gat ctg gtg tt - #t cag agt aag cgt gag1219Pro Phe Ile Tyr Cys Val Glu Asp Leu Val Ph - #e Gln Ser Lys Arg Glu# 120- gaa tgg gaa tct tgt ttt gag aaa ctg gat ct - #t gat tcg gaa cct att1267Glu Trp Glu Ser Cys Phe Glu Lys Leu Asp Le - #u Asp Ser Glu Pro Ile# 135- aat cag tgt tat aat agt gaa cat gga aaa ca - #g gttggtgttt ttctctgatt1320Asn Gln Cys Tyr Asn Ser Glu His Gly Lys Gl - #n# 145- tcgctcttgt ccttgcttga gctaccatgt tgtgattgag atagtattat gt - #acattagt1380- ttagttttca tgccctccga gtgtaagtat gacttgtaaa ctagttacta ca - #aagtattc1440- taagatccta tttggataaa atttgttaca aatacttgca ggtgaagaaa at - #aagaagat1500- aaaataaatt gagtttttct tccgtgagtt aaaatcaaat caacttcggc ac - #ctcggatt1560- ttggaagagt taaatgagac tgagaacttt tatggaagtt tagtgttaag tt - #gattttag1620- cttgtgagag aagctcaatt tattttactt tcttattttc tcatcttata ag - #tgcttatg1680- aaaaagttga tctaaacagg acttaaaatg tttttaacta acctttctct tc - #tatggttg1740- ttttttatga accttaaagt tatactaaca ttgctaaatg atacaagcta gt - #ggaaagtt1800- gggaattaga aaatttgaac agttatacag ttacagggtt ggtggtgact tc - #tcaattcc1860- ttatttaaac taatcttaag tgtcatagat aattgaatct tcttcgaggt ga - #gatataat1920- ccatgtcaac tagccgtaac tgggctctgt tatgtgaaac ttggatggta ag - #gtctggta1980- tttgttatgt gccggtctac tactttgctt ttattcttca agacaacaaa at - #gaaatagc2040- taatgagaag taattttaac ttattccagc aattacttca aaaattggtc at - #gttcttca2100- tttttacaaa actctaaagc agtgtaatat gatctacaaa ttaccttatt gt - #catacatg2160- attgctcttt gctacagata ctgccacacg atctaataga actgccaatt tg - #tagcttct2220- gaacattcat ctttcttcaa gctaatttct caaaatcctt tttcaatctt gc - #tgaatgtg2280- aagactatct cttgatgaaa aacaaaacat atgacagatg tgctgaatac at - #cattgttt2340- gactggaatt ttgtctcaag tagcatttac tatcttgttt tgatcattag ta - #acatttac2400- tatctttatg tag ttg gag cta caa tat gca gct ga - #a aca agt gct ctg2449#Leu Gln Tyr Ala Ala Glu Thr Ser Ala Leu# 160- gag cct cct cac aag tat gtt cct tgg gta gt - #t gtg gat gga gaa cca2497Glu Pro Pro His Lys Tyr Val Pro Trp Val Va - #l Val Asp Gly Glu Pro# 175- ctc tat gag gtcagttttg caattttata tcggctgaac caagcccca - #t2546Leu Tyr Glu- tcccagtgtt tggaattttc actaaaaaat acttctaatt aacaaataac tt - #ataacact2606- gaaatttgtg ttttacatat gtaagttgtg ttatattaat gaatcgaatt ag - #aagtgtac2666- aggaaattca aaaagaactt gcaaatttct tttgctgcag gat tat ga - #g aac ttc2721# Asp Tyr Glu Asn Phe# 180- tta agc tat ctt tgt aag gct tat aaa ggc ac - #t gtt aca ccc caa agt2769Leu Ser Tyr Leu Cys Lys Ala Tyr Lys Gly Th - #r Val Thr Pro Gln Ser185 1 - #90 1 - #95 2 -#00- tgc acc caa gca tca tac cta aga gaa gtg aa - #t gca aag cct aag cat2817Cys Thr Gln Ala Ser Tyr Leu Arg Glu Val As - #n Ala Lys Pro Lys His# 215- tcg gtt tgc tac aag gac agt ggg att atg ct - #a aca tgg gaa aaa gtg2865Ser Val Cys Tyr Lys Asp Ser Gly Ile Met Le - #u Thr Trp Glu Lys Val# 230- agg tca acc att gca tca tgg atg cac tag at - #gaatcttg gcagtgcatt2915Arg Ser Thr Ile Ala Ser Trp Met His# 240- ttagatgtgc caatgctgca tttagtagca gtttgttcgt gttatcttgt gt - #gtagttgt2975- gttgatccct ccaaaagtgc aaatagaact tgtgatgcac ataaaaccat at - #cgtactct3035#3077 ccat gatgtgtatg tgtatgaggt ac- <210> SEQ ID NO 4<211> LENGTH: 79<212> TYPE: PRT<213> ORGANISM: Glycine max- <400> SEQUENCE: 4- Met Val Ser Val Ser Leu Leu Leu Phe Leu Se - #r Phe Phe Ala Phe Phe# 15- Ala Pro Ser Glu Ser His Asp Lys Val Ser Le - #u Glu Leu Tyr Tyr Glu# 30- Ser Leu Cys Pro Tyr Ser Ala Asn Phe Ile Va - #l Asn His Leu Pro Lys# 45- Ile Phe Thr Pro Asp Leu Ala Pro Ile Val Hi - #s Leu Lys Leu Val Pro# 60- Trp Gly Asn Ala Lys Leu Arg Ala Asn Ala Th - #r Phe Asp Cys Gln# 75- <210> SEQ ID NO 5<211> LENGTH: 22<212> TYPE: PRT<213> ORGANISM: Glycine max- <400> SEQUENCE: 5- His Gly Pro Tyr Glu Cys Leu Leu Asn Thr Va - #l Glu Ala Cys Ala Ile# 15- His Ile Trp Pro Gln Leu 20- <210> SEQ ID NO 6<211> LENGTH: 47<212> TYPE: PRT<213> ORGANISM: Glycine max- <400> SEQUENCE: 6- Ser Lys His Phe Pro Phe Ile Tyr Cys Val Gl - #u Asp Leu Val Phe Gln# 15- Ser Lys Arg Glu Glu Trp Glu Ser Cys Phe Gl - #u Lys Leu Asp Leu Asp# 30- Ser Glu Pro Ile Asn Gln Cys Tyr Asn Ser Gl - #u His Gly Lys Gln# 45- <210> SEQ ID NO 7<211> LENGTH: 31<212> TYPE: PRT<213> ORGANISM: Glycine max- <400> SEQUENCE: 7- Leu Glu Leu Gln Tyr Ala Ala Glu Thr Ser Al - #a Leu Glu Pro Pro His# 15- Lys Tyr Val Pro Trp Val Val Val Asp Gly Gl - #u Pro Leu Tyr Glu# 30- <210> SEQ ID NO 8<211> LENGTH: 62<212> TYPE: PRT<213> ORGANISM: Glycine max- <400> SEQUENCE: 8- Asp Tyr Glu Asn Phe Leu Ser Tyr Leu Cys Ly - #s Ala Tyr Lys Gly Thr# 15- Val Thr Pro Gln Ser Cys Thr Gln Ala Ser Ty - #r Leu Arg Glu Val Asn# 30- Ala Lys Pro Lys His Ser Val Cys Tyr Lys As - #p Ser Gly Ile Met Leu# 45- Thr Trp Glu Lys Val Arg Ser Thr Ile Ala Se - #r Trp Met His# 60- <210> SEQ ID NO 9<211> LENGTH: 20<212> TYPE: DNA<213> ORGANISM: Artificial Sequence<220> FEATURE:#Sequence:primerRMATION: Description of Artificial- <400> SEQUENCE: 9# 20 ayca- <210> SEQ ID NO 10<211> LENGTH: 32<212> TYPE: DNA<213> ORGANISM: Artificial Sequence<220> FEATURE:#Sequence:primerRMATION: Description of Artificial- <400> SEQUENCE: 10# 32 ccca nggnacrtay tt- <210> SEQ ID NO 11<211> LENGTH: 25<212> TYPE: DNA<213> ORGANISM: Artificial Sequence<220> FEATURE:#Sequence:primerRMATION: Description of Artificial- <400> SEQUENCE: 11# 25 cgag tcagc- <210> SEQ ID NO 12<211> LENGTH: 20<212> TYPE: DNA<213> ORGANISM: Artificial Sequence<220> FEATURE:#Sequence:primerRMATION: Description of Artificial- <400> SEQUENCE: 12# 20 caca__________________________________________________________________________

Plant-derived, asparagine residue-specific endoprotease cDNA and a gene

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Priority Claims (1)